US PREMARKET MOVERS: NVS, TSLA, UNFI, UBER, INTC, RGTI, AMGN, PTON
Premarket trading saw major declines in biotechs led by Novartis' trial miss, while Intel and Rigetti gained on analyst upgrades and government funding.
News detail
ES -0.1%, NQ +0.2%, RTY -0.1% NVS -12.6%, IONS -10.9%, DYN -26.5%, SRPT -11.3%: Novartis' Phase 3 Lp(a)HORIZON study of pelacarsen missed its primary endpoint TSLA +0.4%: FSD Supervised approved for use in Slovenia UNFI +2.5%: EPS beat UBER +1.0%: President and COO purchased 70k shares INTC +5.0%: Upgraded at Northland to Outperform from Market Perform RGTI +7.2%: Secured USD 100mln in US Commerce Department funding AMGN -6.0%: Downgraded at BMO Capital to Market Perform from Outperform PTON -5.9%: Downgraded at Morgan Stanley to Underweight from Equal Weight
Related stocks
8 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
